Ring Therapeutics' Anellogy™ platform aims to usher in a new era of gene therapy using the human commensal virome.

Biotechnology

Education

Ring Therapeutics

Ring Therapeutics' headquarters in Cambridge, MA, United States

Tuyen Ong

Christopher Wright

Dmitriy Bobrovnikov

Kerri Jensen

Kelly Morgan

Dean Profis

Konstantin Konstantinov

Yong S. Chang

Don Ganem

Hari Pujar

Aravind Asokan

Guangping Gao

Kristian Andersen

Avak Kahvejian

Mark Kay

B. Lynne Parshall

The Research and Development team at Ring Therapeutics focuses on advancing the Anellogy™ platform to innovate gene therapy solutions leveraging the human commensal virome. This multidisciplinary team, comprised of scientists and engineers, conducts extensive research, develops therapeutic payloads, and optimizes bioprocesses to enhance the efficacy and safety of gene therapies, driving forward the company's mission to transform patient care.

Research and Development

The Leadership Team at Ring Therapeutics drives strategic direction and operational excellence, guiding the development of the Anellogy™ platform. Comprising key executives across various disciplines, including human resources, scientific innovation, and intellectual property, this team collaborates to foster a culture of innovation and ensure the successful translation of gene therapy research into impactful therapies.

Leadership Team

The Research and Development team at Ring Therapeutics is dedicated to advancing the Anellogy™ platform by conducting innovative research to harness the capabilities of the human commensal virome for gene therapy applications. This multidisciplinary team focuses on vector discovery, in vitro studies, and analytical development to translate cutting-edge scientific insights into effective therapeutic solutions, paving the way for novel treatments in genetic diseases.

The Program Management Team at Ring Therapeutics is responsible for overseeing the strategic planning, execution, and delivery of projects within the Anellogy™ platform. They coordinate cross-functional efforts, ensuring alignment between research, development, and operational goals while managing timelines, resources, and risk assessments to drive innovative gene therapy solutions. Their leadership fosters collaboration and efficiency, supporting the company's mission to transform gene therapy using the human commensal virome.

Program Management Team

The Advisory Team at Ring Therapeutics comprises experts who provide strategic guidance and insights to enhance the development of the Anellogy™ platform. They leverage their extensive knowledge in gene therapy and virology to help shape research directions, drive innovation, and ensure alignment with industry best practices, ultimately aiming to accelerate the advancement of transformative therapies.

Advisory Team

The Research and Development team at Ring Therapeutics is responsible for advancing the Anellogy™ platform by conducting innovative research to harness the human commensal virome for gene therapy applications. This multidisciplinary team collaborates on experimental design, scientific validation, and the translation of research findings into therapeutic solutions, ensuring the alignment of scientific endeavors with clinical development and regulatory requirements.

��

Ring Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Research and Development

Program Management Team

Advisory Team

Research and Development

Offices

��������

Ring Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Research and Development

Program Management Team

Advisory Team

Research and Development

Offices

Related companies

��